SNCA and synucleinopathy: Thus, subsequent research on microglial cell activation and neuroinflammation in the toxicity of α-synuclein are then critical to establishing a clearer understanding of the pathophysiology of the protein that could further lead to the production of forthcoming synucleinopathy therapeutics.